In a powerful return to the political arena, Barack Obama addresses a crowd in Norfolk, Virginia, delivering scathing critiques of Donald Trump's presidency while rallying support for Democrats like Abigail Spanberger.
In a surprising move, the largest federal workers' union backs a Republican funding bill, igniting tensions with other unions that support Democrats. As the government shutdown drags on, federal workers face pay issues and layoffs.
Over 40 million Americans relying on SNAP benefits face uncertainty after a federal judge's ruling. With a government shutdown in effect, food banks warn of a looming public health crisis as benefits may be delayed.
In a bold move, Trump calls for the Senate to eliminate the filibuster to end the government shutdown, igniting fierce debate as Americans face rising food insecurity and healthcare costs.
Eli Lilly's third-quarter results exceeded estimates, driven by strong demand for Zepbound and Mounjaro. The company raised its revenue forecast, fueling a 5% rise in shares. Discover how Eli Lilly is maintaining its lead in the competitive obesity drug market.
Premiums for Affordable Care Act coverage are set to soar by an average of 26% next year, with the expiration of enhanced subsidies adding to the financial burden for many consumers. Find out how this impacts your health insurance options.
Will Bynum's journey from shame to healing highlights the urgent need for 'shame competence' in medical training. Discover how addressing shame can transform patient care and improve the mental health of future doctors.
In a heated private call, Marjorie Taylor Greene criticized Speaker Mike Johnson over the GOP's handling of the government shutdown, sparking tensions within the party as consequences of inaction loom large.
A new study shows that stillbirths in the U.S. are more common than expected, revealing shocking socioeconomic divides and thousands of unexplained losses in seemingly healthy pregnancies.
Could cannabis be the key to alleviating chronic back pain? New European trials show promising results, challenging the opioid approach. Discover what experts are saying about this groundbreaking research!
